The Heart Outcomes Prevention Evaluation Study

The HOPE Study (Heart Outcomes Prevention Evaluation) - PubMed

The Heart Outcomes Prevention Evaluation (HOPE) study was designed to test the hypotheses that two preventive intervention strategies, ...

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on ...

The double-blind, two-by-two factorial, randomized Heart Outcomes Prevention Evaluation study evaluated ramipril and vitamin E in 9541 patients.

The Heart Outcomes Prevention Evaluation Study - HOPE - Ramipril

The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60. The HOPE (Heart Outcomes Prevention Evaluation) ...

Prevention of Heart Failure in Patients in the Heart Outcomes ...

The HOPE study was a double-blind, placebo-controlled, randomized trial with a two-by-two factorial design conducted to evaluate the effects of ...

Effects of ramipril on cardiovascular and microvascular outcomes in ...

Methods: 3577 people with diabetes included in the Heart Outcomes Prevention Evaluation study, aged 55 years or older, who had a previous cardiovascular ...

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on ...

This article has been corrected. VIEW THE CORRECTION. Author: The Heart Outcomes Prevention Evaluation Study InvestigatorsAuthor Info ...

The Hope Study - Cleveland Clinic Journal of Medicine

The Heart Outcomes Prevention. Evaluation (HOPE) study found that the. ACE inhibitor ramipril can lower the risk of atherosclerotic disease events and.

Clinical, public health, and research implications of the Heart ...

S. Yusuf; Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study, European Heart Journal, Volume 22, I.

The Heart Outcomes Prevention Evaluation Study - HOPE

The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53. The HOPE (Heart Outcomes Prevention Evaluation) ...

The HOPE Study (Heart Outcomes Prevention Evaluation)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction and stroke in high-risk patients.

The HOPE (Heart Outcomes Prevention Evaluation) Study and its ...

The HOPE study was a 19 country, prospective randomized trial in which the ACE‐inhibitor Ramipril but not Vitamin E significantly reduced the ...

The Heart Outcomes Prevention Evaluation (HOPE) Study - Medscape

Overview. The Heart Outcomes Prevention Evaluation (HOPE) study was a landmark study employing the angiotensin-converting enzyme (ACE) inhibitor ramipril in a ...

Effects of ramipril on cardiovascular and microvascular outcomes in ...

3577 people with diabetes included in the Heart Outcomes Prevention Evaluation study, aged 55 years or older, who had a previous cardiovascular event or at ...

The striking effect of the Heart Outcomes Prevention Evaluation ...

We studied whether HOPE affected the prescribing of ACE inhibitors generally, and ramipril specifically, in Ontario, where the trial was coordinated. Methods: ...

Impact of ramipril on the incidence of atrial fibrillation

Coronary Artery Disease. Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study.

The HOPE Study (Heart Outcomes Prevention Evaluation)

The HOPE (Heart Outcome Prevention. Evaluation) study was designed to test the hypotheses that two preventative intervention strategies, namely. ACE inhibition ...

The HOPE (Heart Outcomes Prevention Evaluation) Study and its ...

The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences Journal Articles ... heart failure but at high-risk of cardiovascular events. It ...

Long-Term Effects of Ramipril on Cardiovascular Events and on ...

The Heart Outcomes Prevention Evaluation (HOPE) study demonstrated that 4.5 years of treatment ... The Heart Outcomes Prevention Evaluation Study ...

Heart Outcomes Prevention Evaluation (HOPE) Investigators: Effects ...

Heart Outcomes Prevention Evaluation (HOPE) Investigators: Effects of ramipril on cardiovascular ... study and MICRO-HOPE substudy. Lancet 355:253-259, 2000.

Heart Outcomes Prevention Evaluation Study – GPnotebook

designed to investigate the effects of taking an ACE inhibitor ramipril and/or vitamin E for at least 4 years, on a wide range of vascular ...